Mansukh Mandaviya calls for mandatory adoption of Good Manufacturing Practices by all pharma companies

The GMP was first incorporated in Schedule M in 1988 and the last amendment was done in 2018. "The Schedule M (of the Drugs and Cosmetics Act) has not been implemented properly by the majority of the drugmakers," he said.

Also, observations from ongoing risk-based inspections further reiterated the need to have a re-look at the current GMP regulations and quality management systems being followed by pharmaceutical manufacturers, the health ministry said in a statement. Recently, drug regulators inspected 162 units and 14 public testing labs and major issues found during inspections are poor documentation, lack of process and analytical validations, absence of quality failure investigation, absence of internal product quality review and faulty design of manufacturing and testing areas, among others.

"Based on these factors and to keep pace with fast-changing manufacturing and quality domain, there was a necessity to revisit and revise the principles and concept of GMP mentioned in current Schedule M. "This would bring our GMP recommendations and compliance expectation at par with global standards, specially to those of WHO, and ensure production of globally acceptable quality of drug," the statement said.

Some of the major changes which will happen with the introduction of revised Schedule M to support the upgradation of the units are the introduction of Pharmaceutical Quality System (PQS), Quality Risk Management (QRM), Product Quality Review (PQR), qualification and validation of equipment, change control management, self-inspection & quality audit team, suppliers audit and approval, stability studies as per recommended climate condition, validation of GMP-related computerised system, specific requirements for manufacturing of hazardous products, biological products, radiopharmaceutical and phytopharmaceuticals. This will address most of the deficiencies related to documentation, failure investigation and technically qualified personnel with the right person doing the right job. It will support the development of a robust quality management system in the company thereby enabling the production of globally acceptable quality medicine, the ministry said.

Read also: India has become Pharmacy of World, now it is time for India to become Factory of World: Dr Mansukh Mandaviya